Articles Tagged With: Infusion
-
Is Autologous Bone Marrow Cell Therapy a Potential Treatment for Traumatic Brain Injury?
This study proposes that autologous bone marrow mononuclear intravenous infusion for severe traumatic brain injury in children appears safe and potentially may be efficacious.
-
Brentuximab Neuropathy
Brentuximab, an antibody-drug conjugate for the treatment of lymphomas, carries a high risk of inflammatory sensory and motor neuropathies.
-
Ceftobiprole Medocaril Sodium for Injection (Zevtera)
The U.S. Food and Drug Administration has approved a new cephalosporin antibacterial for the treatment of three serious infections: bloodstream, skin and skin structure, and community-acquired pneumonia. Ceftobiprole is a fifth-generation cephalosporin with in vitro activity against gram-positive and gram-negative bacteria including multidrug resistant organisms. It will be distributed by Basilea Pharmaceutica International Ltd, Allschwil as Zevtera.
-
Ketamine for Super-Refractory Status Epilepticus
In this retrospective paper, the authors review the efficacy and safety of ketamine infusion in patients with status epilepticus who have failed benzodiazepine, standard anticonvulsant, and at least one other anesthetic drip.
-
Efficacy of Vitamin C Infusion on Outcomes in Sepsis-Induced ARDS
In this randomized, double-blinded, placebo-controlled trial, intravenous vitamin C infusion did not influence a change in the modified Sequential Organ Failure Assessment score from the time of infusion to four days compared to placebo.
-
Prolonged vs. Short Duration Infusion of Beta-lactam Antibiotics: The Verdict Is In
When compared to shorter infusion duration, prolonged infusion of anti-pseudomonal β-lactam antibiotics was associated with reduced mortality.
-
Intravenous Nutrient Therapies — Worth the Cost?
Intravenous nutrient therapies are gaining in popularity to help patients maintain overall wellness, enhance weight loss, boost immune function, increase athletic performance, cure hangovers, and treat particular conditions. However, the increase in the use of these therapies in both healthy individuals and those with health conditions has not translated into increased published research studies investigating efficacy and safety.
-
NIST explains why infusion pumps are weak link
The National Institute of Standards and Technology (NIST) in Gaithersburg, MD, recently issued a report on the security risk from infusion pumps.
-
Infusion pumps are weak link in data security
Cyber security experts and healthcare leaders are warning that the biggest threat to your hospital system’s data security might be one of the most innocuous, seemingly harmless devices that doesn’t even appear to have anything to do with your computer system: the infusion pump.
-
Fresenius slapped with record FCA settlement worth $486B